Skip Navigation

JNCI Journal of the National Cancer Institute 1990 82(20):1621-1624; doi:10.1093/jnci/82.20.1621
© 1990 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Grieg, N. H.
Right arrow Articles by Rapoport, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grieg, N. H.
Right arrow Articles by Rapoport, S. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 82, No. 20, 1621-1624, October 17, 1990
© 1990 Oxford University Press

Increasing Annual Incidence of Primary Malignant Brain Tumors in the Elderly

Nigel H. Grieg*,, Lynn G. Ries, Rosemary Yancik, Staley I. Rapoport

Laboratory of Neurosciences, National Institute on Aging Bethesda, Md.
Division of Cancer Prevention and Control, National Cancer Institute Bethesda, Md.
Office of Extramural Research, National Institute of Health Bethesda, Md.

*Correspondence to: Nigel Greig, Ph.D., Bldg. 10, Rm. 6C-103, National Institutes of Health, Bethesda, MD 20892.

Between 1973 and 1985, total age-adjusted cancer incidence in the United States (all races, men and women) rose by 10.7%, with an average annual percentage change of +0.9%. Analysis of reported age-specific incidence of primary malignant brain tumors over the same years demonstrates that incidence rates increased dramatically between 1973/1974 and 1985. In 1985, incidence rates for persons aged 75–79, 80–84, and 85 years of age and over were 187%, 394%, and 501%, respectively, of rates in 1973/1974. Similar increases were found in both men and women, analyzed separately and combined. Average annual percentage changes in primary brain tumor incidence were +7.0%, +20.4%, and +23.4% in these age ranges, respectively. Reported incidence in younger persons varied little over the same period of time. The most common histologic type of primary brain tumor in the elderly was of glial origin, predominantly the glioblastoma multi-forme and astrocytoma. These tumors are highly malignant and invariably fatal. Two possible causes may explain the increased incidence in the elderly; the introduction and extensive use of x-ray computed tomography since 1973 and/or a true increase in incidence occuring independently of diagnostic advances.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
S. Hoffman, J. M. Propp, and B. J. McCarthy
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999
Neuro-oncol, January 1, 2006; 8(1): 27 - 37.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
M. van Tongeren, T. Mee, P. Whatmough, L. Broad, M. Maslanyj, S. Allen, K. Muir, and P. McKinney
Assessing occupational and domestic elf magnetic field exposure in the uk adult brain tumour study: results of a feasibility study
Radiat Prot Dosimetry, February 1, 2004; 108(3): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
P. J. Jukich, B. J. McCarthy, T. S. Surawicz, S. Freels, and F. G. Davis
Trends in incidence of primary brain tumors in the United States, 1985-1994
Neuro-oncol, July 1, 2001; 3(3): 141 - 151.
[Abstract] [PDF]


Home page
NeurologyHome page
M. J. Glantz, B. F. Cole, P. A. Forsyth, L. D. Recht, P. Y. Wen, M. C. Chamberlain, S. A. Grossman, and J. G. Cairncross
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 23, 2000; 54(10): 1886 - 1893.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. L. Chow, Y. P. Gobin, T. Cloughesy, J. W. Sayre, J. P. Villablanca, and F. Viñuela
Prognostic Factors in Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma Treated with Selective Intra-arterial Chemotherapy
AJNR Am. J. Neuroradiol., March 1, 2000; 21(3): 471 - 478.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
J. M. Legler, L. A. G. Ries, M. A. Smith, J. L. Warren, E. F. Heineman, R. S. Kaplan, and M. S. Linet
Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality
J Natl Cancer Inst, August 18, 1999; 91(16): 1382 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. M. Fathallah-Shaykh and D. D. McIntire
Brain Tumors in the Elderly: Undefeated and Gaining Ground
Arch Neurol, July 1, 1998; 55(7): 905 - 906.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. K. Lowry, J. J. Snyder, and P. W. Lowry
Brain Tumors in the Elderly: Recent Trends in a Minnesota Cohort Study
Arch Neurol, July 1, 1998; 55(7): 922 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Kuratsu and Y Ushio
Epidemiological study of primary intracranial tumours in elderly people
J. Neurol. Neurosurg. Psychiatry, July 1, 1997; 63(1): 116 - 118.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. E. Riggs
Rising Primary Malignant Brain Tumor Mortality in the Elderly: A Manifestation of Differential Survival
Arch Neurol, June 1, 1995; 52(6): 571 - 575.
[Abstract] [PDF]


Home page
ScienceHome page
B. Henderson, R. Ross, and M. Pike
Toward the primary prevention of cancer
Science, November 22, 1991; 254(5035): 1131 - 1138.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.